Block Listing 6 Monthly Return

AI SummaryClose X

Shield Therapeutics plc has provided a six-monthly update on its block listing returns for various share schemes covering the period from January 1, 2026, to June 30, 2026. The Shield Therapeutics Retention Share Plan has a remaining balance of 39,794 unallotted securities, while the Shield Therapeutics plc 2016 Company Share Option Plan has 341,020 unallotted securities. The Shield Therapeutics plc 2016 Long Term Incentive Plan has 24,273 unallotted securities. Notably, the Shield Therapeutics Retention and Performance Share Plan saw 2,023,801 securities issued during the period, reducing its balance of unallotted securities to 9,697,164 from an initial 11,720,965. No increases were applied to any of the block schemes during this reporting period.

Disclaimer*

UK 100

Latest directors dealings